# Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea

> **NCT01268891** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 132 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** Azilect®

## Key facts

- **NCT ID:** NCT01268891
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-06
- **Final completion:** —
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2013-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01268891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01268891, "Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01268891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*